Total Payments
$79,536
2024 Payments
$3,748
Companies
55
Transactions
1,087
Medicare Patients
25,291
Medicare Billing
$4.1M
Payment Breakdown by Category
Other$46,060 (57.9%)
Food & Beverage$24,313 (30.6%)
Travel$6,381 (8.0%)
Consulting$2,115 (2.7%)
Education$666.53 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,060 | 20 | 57.9% |
| Food and Beverage | $24,313 | 1,024 | 30.6% |
| Travel and Lodging | $6,381 | 19 | 8.0% |
| Consulting Fee | $2,115 | 3 | 2.7% |
| Education | $666.53 | 21 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $41,501 | 153 | $0 (2024) |
| Amgen Inc. | $10,748 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,928 | 108 | $0 (2024) |
| Novo Nordisk Inc | $2,412 | 19 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,339 | 24 | $0 (2020) |
| Boston Scientific Corporation | $2,288 | 14 | $0 (2024) |
| CVRx, Inc. | $2,032 | 26 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,328 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,063 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,019 | 62 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,748 | 102 | CVRx, Inc. ($1,093) |
| 2023 | $5,488 | 117 | Boston Scientific Corporation ($1,849) |
| 2022 | $3,397 | 145 | Boehringer Ingelheim Pharmaceuticals, Inc. ($476.21) |
| 2021 | $4,931 | 140 | Novo Nordisk Inc ($2,217) |
| 2020 | $1,731 | 96 | Boehringer Ingelheim Pharmaceuticals, Inc. ($246.86) |
| 2019 | $17,456 | 163 | Janssen Pharmaceuticals, Inc ($13,157) |
| 2018 | $18,330 | 152 | Janssen Pharmaceuticals, Inc ($13,675) |
| 2017 | $24,454 | 172 | Janssen Pharmaceuticals, Inc ($13,819) |
All Payment Transactions
1,087 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $435.48 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $107.03 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $97.70 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $362.95 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.02 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $12.24 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cardiology | ||||||
| 09/14/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $127.38 | General |
| Category: Structural Heart | ||||||
| 09/14/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Structural Heart | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 6,966 | 17,545 | $2.6M | $1.2M |
| 2022 | 46 | 6,617 | 11,896 | $2.0M | $1.0M |
| 2021 | 42 | 6,014 | 10,950 | $1.9M | $968,990 |
| 2020 | 44 | 5,694 | 11,018 | $2.0M | $902,114 |
Total Patients
25,291
Total Services
51,409
Medicare Billing
$4.1M
Procedure Codes
185
All Medicare Procedures & Services
185 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,728 | 4,817 | $809,352 | $458,078 | 56.6% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 39 | 39 | $307,965 | $135,380 | 44.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 776 | 792 | $257,582 | $118,761 | 46.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 153 | 155 | $175,308 | $102,682 | 58.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 207 | 207 | $157,852 | $71,935 | 45.6% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 207 | 413 | $82,600 | $64,785 | 78.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 118 | 383 | $62,816 | $36,977 | 58.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 285 | 285 | $73,997 | $35,270 | 47.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 145 | 190 | $60,785 | $26,499 | 43.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 100 | 101 | $32,327 | $14,841 | 45.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,006 | 1,245 | $33,378 | $13,864 | 41.5% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 34 | 34 | $30,454 | $12,978 | 42.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 179 | 551 | $26,613 | $12,226 | 45.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 251 | 251 | $27,838 | $12,111 | 43.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 205 | 630 | $26,095 | $10,411 | 39.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 76 | 161 | $12,354 | $8,158 | 66.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 29 | 29 | $46,769 | $7,204 | 15.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 47 | 293 | $12,303 | $5,890 | 47.9% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 192 | 193 | $10,615 | $5,713 | 53.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 48 | 302 | $7,550 | $5,589 | 74.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 31 | 31 | $8,343 | $5,206 | 62.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 97 | 119 | $14,875 | $5,170 | 34.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 124 | 172 | $15,594 | $4,772 | 30.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $27,012 | $4,376 | 16.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 27 | 27 | $8,339 | $3,973 | 47.6% |
About Dr. Howard Tee, MD
Dr. Howard Tee, MD is a Cardiovascular Disease healthcare provider based in Vero Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972543486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Tee, MD has received a total of $79,536 in payments from pharmaceutical and medical device companies, with $3,748 received in 2024. These payments were reported across 1,087 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($46,060).
As a Medicare-enrolled provider, Tee has provided services to 25,291 Medicare beneficiaries, totaling 51,409 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 185 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Vero Beach, FL
- Active Since 06/07/2006
- Last Updated 12/14/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972543486
Products in Payments
- XARELTO (Drug) $41,458
- Repatha (Biological) $10,263
- PRADAXA (Drug) $2,485
- Ozempic (Drug) $2,331
- Reveal LINQ (Device) $2,264
- Barostim Neo System (Device) $2,032
- WATCHMAN Access System (Device) $1,875
- JARDIANCE (Drug) $1,443
- MULTAQ (Drug) $961.89
- Livalo (Drug) $943.28
- ELIQUIS (Drug) $823.84
- VERQUVO (Drug) $744.01
- ENTRESTO (Drug) $701.34
- Corlanor (Drug) $485.04
- AMPLATZER AMULET (Device) $442.57
- FARXIGA (Drug) $427.00
- BRILINTA (Drug) $425.73
- LifeVest (Device) $393.64
- NORTHERA (Drug) $367.26
- PRALUENT (Drug) $366.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Vero Beach
Dr. Vijay Haryani, Md, MD
Cardiovascular Disease — Payments: $523,428
Cardiovascular Disease $523,428
Arley Peter, M.d, M.D
Cardiovascular Disease — Payments: $53,934
Cardiovascular Disease $53,934
Tudor Scridon, M.d, M.D
Cardiovascular Disease — Payments: $13,259
Cardiovascular Disease $13,259
Dr. Leon Hendley, M.d, M.D
Cardiovascular Disease — Payments: $12,364
Cardiovascular Disease $12,364
Dr. Robert Hendley
Cardiovascular Disease — Payments: $10,930
Cardiovascular Disease $10,930
Radu Codel, M.d, M.D
Cardiovascular Disease — Payments: $10,332
Cardiovascular Disease $10,332